As Carcinotech passes its fourth birthday, we are looking to the future. This includes a fresh new rebrand. Introducing our new look.
Read the full article here
Carcinotech has pioneered the development of assay-ready, 3D-bioprinted tumours derived from patient biopsies for oncology drug discovery and development.